Blood Test Predicts Dementia in Women as Many as 25 Years Before Symptoms Begin
Measured in blood samples, the biomarker p-tau217 was strongly linked to future dementia risk across decades of follow-up in a large, diverse cohort of U.S. women.
Measured in blood samples, the biomarker p-tau217 was strongly linked to future dementia risk across decades of follow-up in a large, diverse cohort of U.S. women.
By utilizing long-read sequencing, an emerging technique that reads large sections of the genome at once, scientists at UC San Diego have revealed new genetic variants associated with autism spectrum disorder.
There is no evolutionary signal suggesting that these viruses were being “pre-adapted” for humans prior to their outbreaks. Instead, measurable changes in selection typically appeared only after sustained transmission began in people.
“We provide a larger platform so that others can start to make broader connections to see patterns and gaps across fields that usually don’t talk to each other," says Professor Imanuel Lerman.
A new discovery from UC San Diego researchers could enable easier treatment of high-grade serous ovarian cancer, the most common and aggressive form of ovarian cancer.
With up to $25 million from Cancer Grand Challenges, an international team led by UC San Diego professor Ludmil Alexandrov will unlock the secrets of DNA's "fingerprints."
SELF Magazine, April 14
The New York Times, April 3
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
You have been successfully subscribed to the UC San Diego Today Newsletter.